RESF was a Scandinavian registry ran by NAFKAM, containing information from people who had experienced that their use of CAM had affected their course of disease.
From Jan 1, 2021, NAFKAM no longer accepted inquiries about registration of improvement or deterioration as a result of the use of CAM. The registry was formally discontinued on Dec 31, 2024.
Patients who experience improvement or deterioration of their health and attribute this to their use of CAM, are advised to inform both their CAM provider as well as their MD/ GP.
